News
Shares of Venus Remedies rose 14.3% to ₹356.65 after the US FDA granted QIDP designation to its product VRP-034, targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback